 Acute mountain sickness affects approximately 2550 of newcomers to high altitudes . Two human carbonic anhydrase isoforms hCA I and II play key roles in developing high altitude illnesses . However the only FDA approved drug for AMS is acetazolamide which has a nearly 100 times weaker inhibitory activity against hCA I

@highlight  quinary heterocycles 4 sulfamoylbenzamides were potent dual hCA I II inhibitors.
@highlight The quinary heterocycles reinforced the interaction between the titled compounds and hCA I II
@highlight The selected compounds
@highlight and
@highlight possessed powerful anti hypoxia activities
@highlight The selected compounds
@highlight and
@highlight showed no obvious toxicity
